2022 American Transplant Congress
Histologic Borderline Reflects Molecular Injury Not Rejection: Results from the Trifecta Study
*Purpose: In the Trifecta study (NCT04239703), we recently compared indication biopsy diagnoses (MMDx and histology) and plasma %dd-cfDNA levels for indication biopsies (JASN in press…2022 American Transplant Congress
Implementation of Infectious Disease Surveillance in Recently Deceased Human Xenograft Study
NYU Langone Transplant Institute, New York, NY
*Purpose: Xenotransplantation is a promising solution for the ongoing organ shortage but has been slow to develop because of both immunological challenges and potential risk…2022 American Transplant Congress
Medical Necessity Kidney Donation in the Treatment Algorithm for Nutcracker Syndrome: Transforming Pain to Altruism
Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT
*Purpose: Patients with nutcracker syndrome (NCS) are often presented with multiple treatment pathways, including interventional and surgical options. In those who elect native nephrectomy, consideration…2022 American Transplant Congress
Early Outcomes of Single Dose Eculizumab for Abo-Incompatible Living Donor Renal Transplantation
*Purpose: Use of ABO-incompatible (ABOi) donors increases access to living donor renal transplantation (LDRT). Conventional desensitization with plasmapheresis (PLEX) allows safe ABOi transplantation when pre-transplant…2022 American Transplant Congress
Single Center Assessment of Completing Kidney Evaluations: Race and Ethnicity Were Not Predictors for Preemptive Kidney Transplant Patients
Houston Methodist, Houston, TX
*Purpose: This study examines the differential progress from beginning the transplant evaluation process to its completion and subsequent presentation to the Candidate Selection Committee (CSC)…2022 American Transplant Congress
Use of Monoclonal Antibody Casirivimab-Imdevimab for Treatment of COVID-19 in Kidney Transplant Recipients
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Kidney transplant recipients are at high-risk for severe coronavirus disease 2019 (COVID-19). Studies suggest that intervention with monoclonal antibody (MAB) treatment may decrease hospitalization…2022 American Transplant Congress
Attitudes Regarding COVID-19 Vaccine and Vaccine Hesitancy in an Inner-City Kidney Transplant Recipients (KTRs)
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: KTRs comprise a high-risk group for COVID-19 infection due to comorbidities and immunosuppression. Studying how vaccination hesitancy in inner-city KTRs has changed since the…2022 American Transplant Congress
XR Tacrolimus Dosing By Ideal Body Weight Reduces Incidence Of Early Supratherapeutic Tacrolimus Concentrations
Pharmacy, NewYork-Presbyterian Hospital, New York, NY
*Purpose: At our center, the use of de novo Envarsus XR® (extended-release [XR] tacrolimus) dosed at 0.12 mg/kg is standard of care in adult kidney…2022 American Transplant Congress
Month 1 Donor Derived Cell Free DNA Levels Predict Future Kidney Transplant Rejection
1Northwestern University, Chicago, IL, 2Transplant Nephrology, Northwestern University, Chicago, IL
*Purpose: The purpose of this study was to determine if donor-derived cell-free DNA (dd-cfDNA) can be used one-month post-transplant to predict later allograft rejection.*Methods: Retrospective…2022 American Transplant Congress
COVID-19 Vaccination Induces a Poor Interleukin-21 Memory T-cell Response in Kidney Transplant Recipients
*Purpose: COVID-19-related morbidity and mortality is high among kidney patients. Several studies recently suggested low humoral and cellular immune responses after two doses of mRNA-1273…
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 531
- Next Page »